metadata toggle
Clinical particulars
Target species
Cattle (milk cows).
Indications for use, specifying the target species
Indicated in the treatment of acute and subacute bovine mastitis in milking cows, accompanied by pain and inflammation caused by bacterial infection sensitive to penicillin, streptomycin and neomycin therapy.
Contraindications
None.
Special Warnings for each target species
No special warnings.
Special precautions for use
Special precautions for use in animals
During a course of treatment the situation should be reviewed frequently by close veterinary supervision.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Protective gloves should be worn when infusing heifers, to avoid skin contact with the product.
Penicillins and cephalosporins may cause hypersensitivity following injection, inhalation, ingestion, or skin contact. Hypersensitivity to penicillins may lead to cross-reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.
Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.
Handle this product with great care to avoid exposure, taking all recommended precautions.
If you develop symptoms following exposure such as skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention.
Wash hands after use.
Adverse reactions (frequency and seriousness)
No known undesirable effects.
Use during pregnancy, lactation or lay
This product can be safely administered to cows during pregnancy or lactating. Also see warning in section, "Withdrawal period" regarding withdrawal periods.
Interaction with other medicinal products and other forms of interaction
None known
Amounts to be administered and administration route
The contents of one syringe should be infused gently into each infected quarter via the teat canal immediately after milking, once daily for three consecutive days. Aseptic precautions should be observed at all times.
Overdose (symptoms, emergency procedures, antidotes), if necessary
Not applicable.
Withdrawal period
Milk for human consumption must not be taken from a cow during treatment. Milk for human consumption may only be taken from 108 hours from the last treatment.
Animals must not be slaughtered for human consumption during treatment. Cattle may be slaughtered for human consumption only after 7 days from the last treatment.